Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAN KIN CHOW

Eye and Vision Services Providers Optometrist

NPI
1417307620
CMS profile
3960967
Location
MIAMI, FL

General Payments · PY2018–2024

$18,345.94

  • Reported across 92 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,229.97

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
CooperVision Inc. $2,372.18 6
Bausch & Lomb Americas Inc. $604.42 5
Dompe US, Inc. $139.70 1
Tarsus Pharmaceuticals, Inc. $58.59 1
Johnson & Johnson Vision Care, Inc. $55.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $301.05 5
PY2019 $949.69 10
PY2020 $456.67 6
PY2021 $3,964.93 21
PY2022 $3,208.75 20
PY2023 $6,234.88 16
PY2024 $3,229.97 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Bausch & Lomb Americas Inc. $109.73 01/02/2024 Food and Beverage Undisputed 01/23/2026 1140400066 CMS
Bausch & Lomb Americas Inc. $118.27 02/23/2024 Food and Beverage Undisputed 01/23/2026 1140400068 CMS
Bausch & Lomb Americas Inc. $129.60 07/11/2024 Food and Beverage Undisputed 01/23/2026 1140400070 CMS
Bausch & Lomb Americas Inc. $124.43 10/17/2024 Food and Beverage Undisputed 01/23/2026 1140400074 CMS
Bausch & Lomb Americas Inc. $122.39 11/12/2024 Food and Beverage Undisputed 01/23/2026 1140400072 CMS
CooperVision Inc. $30.72 02/05/2024 Food and Beverage Undisputed 01/23/2026 1145466957 CMS
CooperVision Inc. $76.68 02/08/2024 Food and Beverage Undisputed 01/23/2026 1145466951 CMS
CooperVision Inc. $27.52 07/23/2024 Food and Beverage Undisputed 01/23/2026 1145467041 CMS
CooperVision Inc. $1,500.00 11/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1145467087 CMS
CooperVision Inc. $39.16 11/11/2024 Food and Beverage Undisputed 01/23/2026 1145467089 CMS
CooperVision Inc. $698.10 11/11/2024 Travel and Lodging Undisputed 01/23/2026 1145467091 CMS
Dompe US, Inc. $139.70 05/07/2024 Food and Beverage Undisputed 01/23/2026 1151410099 CMS
Johnson & Johnson Vision Care, Inc. $55.08 04/29/2024 Food and Beverage Undisputed 01/23/2026 1077700409 CMS
Tarsus Pharmaceuticals, Inc. $58.59 12/24/2024 Food and Beverage Undisputed 01/23/2026 1139088868 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.